New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
about
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.Making Meaningful Clinical Use of BiomarkersA restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomasInflammation-related microRNA expression level in the bovine milk is affected by mastitis.Serum Levels of MicroRNA-206 and Novel Mini-STR Assays for Carrier Detection in Duchenne Muscular Dystrophy.The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance.Identification of Autophagy-Related Genes and Their Regulatory miRNAs Associated with Celiac Disease in Children.Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.Extracellular miRNAs as biomarkers in cancer.What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes.Differential miR-346 and miR-582-3p Expression in Association with Selected Maternal and Fetal Complications.miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans.Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder.MicroRNA Signaling in Embryo Development.MicroRNAs as Biomarkers in Thyroid Carcinoma.Methods and novel technology for microRNA quantification in colorectal cancer screening.Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks?Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.Cell-to-cell communication: microRNAs as hormones.miRNAs, Melanoma and Microenvironment: An Intricate Network.The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.Convenient Monitoring System of Intracellular microRNA Expression during Adipogenesis via Mechanical Stimulus-Induced Exocytosis of Lipovesicular miRNA Beacon.Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma.Serum, plasma and saliva biomarkers for head and neck cancer.Unpacking Major Depressive Disorder: From Classification to Treatment Selection.Epigenetics: The Future Direction in Systemic Sclerosis.Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.Analysis of serum microRNA expression in male workers with occupational noise-induced hearing loss.Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies.Can nanotechnology improve cancer diagnosis through miRNA detection?Human salivary microRNAs in Cancer.Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E.A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancerCirculating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma
P2860
Q33713586-867CDF7D-A90D-4AEC-A709-646343EED536Q33821481-F20B63FB-0763-45EB-A66E-7196B161670CQ36091092-985A397A-53C6-4C63-9B49-0C7C7C25C231Q36375524-4F720738-1D9A-4C65-92D9-55983EC5F6DAQ37210178-5FA3CC29-859F-4C62-9AB5-D502D29C6181Q38681199-60AAB861-42A7-492B-B29A-F427869098ACQ38716163-BE9841AB-8E60-4500-A9AF-43B8CCC67961Q38755836-D1BEA260-DB3B-4D96-BAFD-48620A13DF87Q38867417-FA1374A4-CB0C-4A33-9516-E2BDA4ED5A6FQ39168132-AF82D6D7-D5CE-4BEA-9C26-35B731E7B97CQ41091907-94E35A1C-E857-4A8B-9ACF-6470D393FAB3Q41183347-26FC6C1B-2C61-4C34-958A-2D9223ACE780Q41228775-9D050A46-C5BD-4EE5-B0B2-596FE1A65A6EQ41369374-B66CF553-634B-4E76-943C-41E895DBF8F8Q41663220-F4F2DFAC-7EEA-4730-A0D9-DDB2ABB67184Q42361202-FB8EFECA-0346-46CC-80FB-DF13608EB597Q44385577-9E23153C-AE9B-42AD-B62B-77A8F1F336F1Q46306526-0B96676D-948C-4009-936B-690D8B9D4D26Q47106247-CB95BCD7-2570-43EA-A918-6F600EE60713Q47113309-1C2E5E1C-ABDD-489B-A5F0-03EB61C757C8Q47152593-E3A08F1A-E2DD-4CD2-96C3-AC079AB02927Q47201290-85E89844-7881-4FC3-BBC8-DAD7A577764DQ47216837-A9671827-BBC0-46BE-A040-BD78F2E0EEFBQ47273844-9FDBACF2-296E-4876-8E7F-7811140D70C2Q47359451-99604EEC-C2CE-4AF1-A740-639D683FF8E8Q47405806-C51F4617-9D0B-4008-B619-321008DA15E8Q47668646-64D56922-51EF-4BD7-BFA9-0D5A55D17B1FQ47939031-88970E22-7A3C-4F68-97CA-1C3F471FA53FQ48241732-BEDFF43F-7C7B-48C3-8228-7CBE9CAC8CC4Q50015404-624B7653-E9C6-4671-8089-A231F83631F7Q50063114-6BCEBDAA-8F92-4C48-8A18-3DD78CBE493BQ50097295-030D2774-38F0-4A7B-B1F1-E37EAD5ED6D0Q51028215-1F3B7A5D-9749-4874-A601-8054DA617F38Q52647687-AEB711AA-7A04-4AF2-89F4-FD6983A8A49EQ54918383-5F632984-FB64-409F-9488-DE71A24C119FQ55251496-D7B1FFDC-AF83-400B-A2EA-0CC6ED00BF3BQ55470614-09A7890E-859A-4CB8-83E5-E6A4901F0BE3Q58572333-63F4B1EC-23FF-40C7-A661-26722AAD6E76Q58582706-E86D0901-A16C-49F0-AAC3-E98A5820AF59
P2860
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@ast
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@en
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@nl
type
label
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@ast
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@en
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@nl
prefLabel
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@ast
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@en
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
@en
P2093
Angela M Araujo
Carla Sole
Erika Larrea
Marta Fernandez-Mercado
María Araiz
María Arestin
María Armesto
P2860
P3181
P356
10.3390/IJMS17050627
P407
P5008
P577
2016-04-27T00:00:00Z